Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies

Key Points

• Neuroinflammation is significantly influenced by TLRs and NLRP receptors in Alzheimer's disease, suggesting a critical role in disease progression.
• Inhibiting these pathways may reduce beta-amyloid accumulation and improve cognitive function in affected individuals.
• Analysis of recent therapies targeting TLRs/NLRP receptors offers insights into potential intervention strategies for Alzheimer's.
• Understanding these mechanisms highlights new directions for developing effective neuroinflammation therapies.